Predictors of nonuse of donation after circulatory death lung allografts.


Journal

The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343

Informations de publication

Date de publication:
02 2021
Historique:
received: 21 09 2019
revised: 07 04 2020
accepted: 08 04 2020
pubmed: 22 6 2020
medline: 18 2 2021
entrez: 22 6 2020
Statut: ppublish

Résumé

Despite growing evidence of comparable outcomes in recipients of donation after circulatory death and donation after brain death donor lungs, donation after circulatory death allografts continue to be underused nationally. We examined predictors of nonuse. All donors who donated at least 1 organ for transplantation between 2005 and 2019 were identified in the United Network for Organ Sharing registry and stratified by donation type. The primary outcome of interest was use of pulmonary allografts. Organ disposition and refusal reasons were evaluated. Multivariable regression modeling was used to assess the relationship between donor factors and use. A total of 15,458 donation after circulatory death donors met inclusion criteria. Of 30,916 lungs, 3.7% (1158) were used for transplantation and 72.8% were discarded primarily due to poor organ function. Consent was not requested in 8.4% of donation after circulatory death offers with donation after circulatory death being the leading reason (73.4%). Nonuse was associated with smoking history (P < .001), clinical infection with a blood source (12% vs 7.4%, P = .001), and lower PaO Nontransplantation of donation after circulatory death lungs was associated with potentially modifiable predonation factors, including organ procurement organizations' consenting behavior, and donor factors, including hypoxemia. Interventions to increase consent and standardize donation after circulatory death donor management, including selective use of ex vivo lung perfusion in the setting of hypoxemia, may increase use and the donor pool.

Identifiants

pubmed: 32563573
pii: S0022-5223(20)31078-3
doi: 10.1016/j.jtcvs.2020.04.111
pmc: PMC7647952
mid: NIHMS1591876
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

458-466.e3

Subventions

Organisme : NCI NIH HHS
ID : T32 CA093245
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL069749
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR002555
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Références

J Heart Lung Transplant. 2005 Oct;24(10):1657-64
pubmed: 16210144
Am J Transplant. 2017 Oct;17(10):2679-2686
pubmed: 28470870
Ann Thorac Surg. 2018 Jan;105(1):271-278
pubmed: 29128047
J Thorac Cardiovasc Surg. 2008 Oct;136(4):1061-6
pubmed: 18954650
Eur J Cardiothorac Surg. 2010 Jan;37(1):74-9
pubmed: 19695894
Lancet. 2012 Aug 25;380(9843):747-55
pubmed: 22647758
Am J Respir Crit Care Med. 2013 Mar 1;187(5):527-34
pubmed: 23306540
J Thorac Cardiovasc Surg. 2006 Jan;131(1):73-80
pubmed: 16399297
J Heart Lung Transplant. 2005 Oct;24(10):1460-7
pubmed: 16210117
Am J Transplant. 2012 Sep;12(9):2406-13
pubmed: 22823062
Transpl Int. 2016 Jul;29(7):749-59
pubmed: 26991858
N Engl J Med. 2007 Jul 19;357(3):209-13
pubmed: 17634455
JAMA. 2001 Jan 17;285(3):329-33
pubmed: 11176844
Am J Transplant. 2008 Jun;8(6):1282-9
pubmed: 18444923
Am J Transplant. 2020 Sep;20(9):2466-2480
pubmed: 32157810
Chest. 2000 Nov;118(5):1255-62
pubmed: 11083672
J Thorac Cardiovasc Surg. 2010 May;139(5):1306-15
pubmed: 20412963
J Heart Lung Transplant. 2015 Oct;34(10):1278-82
pubmed: 26454741
J Heart Lung Transplant. 2009 Aug;28(8):753-8
pubmed: 19632569
Am J Transplant. 2016 Apr;16(4):1207-15
pubmed: 26844673
Clin Transplant. 2017 Jul;31(7):
pubmed: 28470765
Ann Thorac Surg. 2018 Dec;106(6):1619-1627
pubmed: 30205113
Chest. 2003 Oct;124(4):1232-41
pubmed: 14555551
J Heart Lung Transplant. 2015 May;34(5):675-84
pubmed: 25638297

Auteurs

Ashley Y Choi (AY)

School of Medicine, Duke University, Durham, NC. Electronic address: choi.ashley@duke.edu.

Oliver K Jawitz (OK)

Department of Surgery, Duke University Medical Center, Durham, NC.

Vignesh Raman (V)

Department of Surgery, Duke University Medical Center, Durham, NC.

Michael S Mulvihill (MS)

Department of Surgery, Duke University Medical Center, Durham, NC.

Samantha E Halpern (SE)

School of Medicine, Duke University, Durham, NC.

Yaron D Barac (YD)

The Division of Cardiovascular and Thoracic Surgery, Rabin Medical Center, Petach-Tikva, Israel.

Jacob A Klapper (JA)

Department of Surgery, Duke University Medical Center, Durham, NC.

Matthew G Hartwig (MG)

Department of Surgery, Duke University Medical Center, Durham, NC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH